ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013
By Prof. Dr. rer. nat. Ulrich Mansmann
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Prof. Dr. rer. nat. Ulrich Mansmann
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 19
Description
34th Annual Conference of the International Society for Clinical Biostatistics, 25 - 29 August 2013 in Munich, Germany.
An array of fascinating topics has been organized by the conference´s Scientific Programme
Committee, including biomarker-based clinical trial designs, statistics for global clinical trials,
and social networks in infectious diseases.
This year´s customary Thursday Symposium will address topics related to individual prediction,
personalized medicine, vaccination, and guidelines for prognostic research, which are sure to
provide stimulating discussions and fuel for thoughts.
| Episode | Date |
|---|---|
|
Penalization Theory and Practice for Cox Models
|
Apr 18, 2019 |
|
Biomarker-based phase III clinical trial: Real-world experiences
|
Apr 18, 2019 |
|
Estimating effects of time-varying treatments: pitfalls and opportunities
|
Apr 18, 2019 |
|
Evaluating and addressing consistency of the evidence in a network metaanalysis
|
Apr 18, 2019 |
|
Recent developments in updating and extending risk prediction models, the European Randomized Study of Prostate Cancer Risk Calculator
|
Apr 18, 2019 |
|
From model building to validation and back: a plea for robustness
|
Apr 18, 2019 |
|
Using network meta-analysis for decision making
|
Apr 18, 2019 |
|
Joint longitudinal survival models for prediction of prostate cancer recurrence following radiotherapy
|
Apr 18, 2019 |
|
Adaptive designs for confirmatory clinical trials with treatment selection
|
Apr 18, 2019 |
|
Recent developments in updating and extending risk prediction models, the Prostate Cancer Prevention Trial Calculator
|
Aug 29, 2013 |
|
Gene signatures as treatment modifiers in clinical trial
|
Aug 29, 2013 |
|
Biomarker-based phase II trial designs
|
Aug 29, 2013 |
|
Utility-Based Dose-Finding with Ordinal Toxicity and Efficacy
|
Aug 29, 2013 |
|
Causal search in high-dimensional settings
|
Aug 29, 2013 |
|
Assessing mediation through multiple pathways using natural effect models
|
Aug 28, 2013 |
|
The meta-analytic approach to validation of surrogate endpoints
|
Aug 28, 2013 |
|
TBD (on meta-regression)
|
Aug 28, 2013 |
|
Two folklores: ridge regression versus the lasso
|
Aug 27, 2013 |
|
Purposeful penalization of likelihood in small samples
|
Aug 27, 2013 |